Search Results For ''

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace

    Industry Growth Opens Doors for Pharma Innovators With the global psychedelic drugs market projected to reach A$14 billion by 2032, and the medical cannabis sector already generating more than A$3 billion annually across Australia, Germany, the UK and the EU, Bioxyne Limited (ASX:BXN) is growing revenues as it meets increased demand. The company announced an

    Read More
    Public
  • dorsaVi Secures Breakthrough Memory Tech to Supercharge Sensor Capabilities

    In a move that impacts the future of wearable sensing and edge computing, Australian motion-analysis company dorsaVi (ASX:DVL) has secured exclusive worldwide rights to a transformative memory technology developed by Singapore’s Nanyang Technological University (NTU). The deal grants dorsaVi access to nine families of resistive random-access memory (RRAM) patents designed to power the next generation

    Read More
    Public
  • Australia’s GDP inches higher in March 2025 quarter

    Australia’s economic growth, as measured by the ABS-compiled chain volume GDP statistics that adjust for price increases, edged higher by a lower than expected 0.2 per cent in the March 2025 quarter. The accompanying ABS-prepared commentary noted that extreme weather events dampened domestic demand and reduced exports. It added that weather impacts were particularly evident

    Read More
    Public
  • Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company

    A Transformative $14 Billion Merger In a bold move that will reshape Australia’s industrial and investment sectors, Washington H. Soul Pattinson (ASX:SOL) and Brickworks (ASX:BKW) have agreed to a transformative merger that will create a new $14 billion ASX-listed entity. The deal will dismantle their long-standing cross-shareholding and replace it with a unified, more investable

    Read More
    Public
  • TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint

    TruScreen Group Limited (NZX/ASX:TRU), a medical device company focused on real-time cervical cancer screening, has raised NZ$2.35 million from a share placement that drew strong interest from  investors across Asia, including some new investors from Singapore and Hong Kong. These additional funds will be used to advance the company’s AI-powered cervical cancer detection technology amid

    Read More
    Public
  • WiseTech Expands Global Footprint with $2.1B Acquisition of e2open

    WiseTech Global (ASX:WTC) has taken a decisive step toward cementing its position as a leading force in global logistics technology, announcing a binding agreement to acquire US-based e2open (NYSE:ETWO) for an enterprise value of US$2.1 billion. The acquisition is poised to transform WiseTech’s global reach and accelerate its vision of becoming the operating system for

    Read More
    Public